[ad_1]
A hemp farm in Colorado. (CNN Photo)
CBD, the chemical found in hemp and marijuana plants, is found in shampoos, lathers, body oils, gummy bears, and dog treats. It is sold in coffee shops and farmers' markets, at grandmothers, in high-end department stores and, more recently, in the CVS pharmacy chain.
"Literally overnight, you see CBD all around you and everywhere," said Troy Dayton, CEO of The Arcview Group, a cannabis research and investment company based in Oakland, California. "It is a product that passes from relative obscurity to the mind of all: producers, consumers and especially entrepreneurs."
The floodgates of the CBD opened after the signature of the Farm Bill by President Donald Trump in December. Among other things, the bill legalized hemp production, which contains high levels of cannabidiol, or CBD. The CBD is not psychoactive, that is to say, it will not rise to the top. (THC, or tetrahydrocannabinol, is the chemical in cannabis that does it.) Instead, CBD is marketed for everything from pain relief and inflammation to stress reduction and l & # 39; anxiety.
Yet the Food & Drug Administration has not yet decided how to regulate CBD products. In a recent interview with the Brookings Institution, outgoing FDA Commissioner Scott Gottlieb said it may be several years before the agency fully legalizes CBD for its use in food products and dietary supplements.
So far, little clinical research has been conducted to prove the effectiveness of the CBD. Last year, the FDA approved the first drug containing CBD for the treatment of some forms of epilepsy, but no other drug has been approved since.
Dayton warns against the lack of standardization of recommended doses and quality control.
"As exciting as it may be, it does raise some challenges," he says. "Standardization and testing are important. Otherwise, it is difficult to differentiate the hype from reality in terms of determining the effectiveness of CBD products. "
[ad_2]
Source link